집
당뇨병 환자 가정 식단 계획 생성
의료 건강
35
35
심각한 합병증이 없는 제2형 당뇨 성인 환자에게 중국 국민 식이 가이드라인에 부합하는 맞춤형 1주일 가정 식단 계획을 생성하며, 삼시 배식, 주의사항과 식이 제안을 포함합니다
프롬프트 내용
복사
복사
Based on the height, weight, daily activity level and flavor preference provided by an adult patient with type 2 diabetes, generate a weekly three-meal home diet plan that meets Chinese dietary guidelines, mark approximate calorie and carbohydrate content for each recipe, and also list foods to avoid and daily dietary precautions.
복사
제2형 당뇨 성인 환자가 제공한 키, 몸무게, 일일 활동량과 맛 선호도에 따라 중국 국민 식이 가이드라인에 부합하는 1주일 가정 삼시 식단 계획을 생성하고 각 레시피마다 대략적인 열량과 탄수화물 함량을 표기하며 동시에 피해야 할 음식과 일일 식이 주의사항을 나열합니다.
복사
의견 (0)
0/300
추천
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Consider the patient's age, liver/kidney function, and allergy history to highlight potential risks and provide adjustment suggestions, ensuring the treatment plan aligns with the latest clinical guidelines.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract drug names, dosages, routes, and frequencies, cross-referencing them with the patient's age, renal/hepatic function, and allergy history. Second, check for drug interactions, contraindications, or off-label usage risks based on current clinical guidelines. Finally, if potential risks are identified, clearly specify the risk type and provide specific adjustment suggestions or alternative solutions, ensuring the output is concise, professional, and adheres to medical safety standards.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all drug names with dosages. Second, cross-reference these details against the latest clinical guidelines and package inserts to check for contraindications, drug-drug interactions, or dosage errors. Finally, if any safety risks are identified, clearly specify the risk and provide evidence-based adjustment suggestions or alternative therapies to support clinical decision-making.
처방전 검토 어시스턴트
Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze whether this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, particularly regarding the risk of using non-steroidal anti-inflammatory drugs in patients with renal insufficiency, and provide specific adjustment suggestions or alternative solutions to ensure medication safety.
처방전 심사 보조
Act as a senior clinical pharmacist and review the following simulated prescription: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and Ibuprofen 400mg tid (for osteoarthritis pain). Analyze if there are drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the risks of NSAID use in patients with renal impairment, and provide specific adjustment suggestions or alternative plans to ensure medication safety and compliance with clinical guidelines.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and a newly prescribed Ibuprofen 400mg tid. Analyze if this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the impact of NSAIDs on renal function and the combined risk with antiplatelet agents, and provide specific adjustment suggestions or warning information to ensure the safety and efficacy of the medication regimen.
